Literature DB >> 8400989

Hepatitis A virus infection. No conclusive link to factor VIII.

C Prowse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400989      PMCID: PMC1678662          DOI: 10.1136/bmj.307.6903.561-e

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Acute hepatitis A in haemophiliacs.

Authors:  A Gerritzen; K E Schneweis; H H Brackmann; J Oldenburg; P Hanfland; W H Gerlich; G Caspari
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

2.  Outbreak of hepatitis A among Italian patients with haemophilia.

Authors:  P M Mannucci
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

3.  Clotting factors and hepatitis A.

Authors:  I J Temperley; K P Cotter; T J Walsh; J Power; I B Hillary
Journal:  Lancet       Date:  1992-12-12       Impact factor: 79.321

4.  Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.

Authors:  P J Simmons; B Torok-Storb
Journal:  Blood       Date:  1991-07-01       Impact factor: 22.113

5.  Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit.

Authors:  K K Lee; L R Vargo; C T Lê; L Fernando
Journal:  Pediatr Infect Dis J       Date:  1992-02       Impact factor: 2.129

6.  Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease.

Authors:  W Kreuz; D Klarmann; G Auerswald; K Auberger; L Gürtler; H Rabenau; W D Doerr
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

7.  Acute hepatitis A in patients with haemophilia A.

Authors:  K Peerlinck; J Vermylen
Journal:  Lancet       Date:  1993-01-16       Impact factor: 79.321

Review 8.  Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.

Authors:  P M Mannucci
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

  8 in total
  1 in total

Review 1.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.